Drug Information for PHOTOFRIN (porfimer sodium) for Injection (Axcan Scandipharm Inc.): INDICATIONS AND USAGE

  • Photodynamic therapy with PHOTOFRIN® is indicated for:

    • Palliation of patients with completely obstructing esophageal cancer, or of patients with partially obstructing esophageal cancer who, in the opinion of their physician, cannot be satisfactorily treated with Nd:YAG laser therapy.
    • Reduction of obstruction and palliation of symptoms in patients with completely or partially obstructing endobronchial non-small-cell lung cancer (NSCLC).
    • Treatment of microinvasive endobronchial NSCLC in patients for whom surgery and radiotherapy are not indicated.
    • Ablation of high-grade dysplasia in Barrett’s esophagus patients who do not undergo esophagectomy.
  • Drug Information Provided by National Library of Medicine (NLM).